Pfizer's 4.9B Obesity Bet: Acquiring Metsera
Markets & Money Today | 2 Min News | The Daily News Now! - A podcast by The Daily News Now! - Wednesdays
Categories:
Pfizer just made a massive $4.9 billion bet on obesity drugs, acquiring Metsera in a deal that sent shockwaves through the market! Why? Metsera's got a hot pipeline of potential weight loss treatments, and Pfizer, after scrapping its own obesity pill, doesn't want to miss out on the booming market dominated by Zepbound and Wegovy. Get ready for a new player in the weight loss game! Hosted on Acast. See acast.com/privacy for more information.
